T Scientific Co.,Ltd. Stock

Equities

A057680

KR7057680001

IT Services & Consulting

End-of-day quote Korea S.E. 18:00:00 2024-04-25 EDT 5-day change 1st Jan Change
1,174 KRW -0.51% Intraday chart for T Scientific Co.,Ltd. -0.42% -29.83%

Financials

Sales 2022 8.69B 6.32M 8.63M Sales 2023 26.77B 19.46M 26.58M Capitalization 115B 83.33M 114M
Net income 2022 -11.11B -8.08M -11.03M Net income 2023 -45.41B -33.02M -45.1M EV / Sales 2022 16.2 x
Net Debt 2022 3.46B 2.52M 3.44M Net cash position 2023 862M 626K 855K EV / Sales 2023 4.25 x
P/E ratio 2022
-11.8 x
P/E ratio 2023
-2.27 x
Employees 200
Yield 2022 *
-
Yield 2023
-
Free-Float 79.1%
More Fundamentals * Assessed data
Dynamic Chart
T Scientific Co.,Ltd. announced that it has received KRW 2.99999997 billion in funding from WIZIT Co., Ltd. CI
T Scientific Co.,Ltd. announced that it expects to receive KRW 2.99999997 billion in funding from WIZIT Co., Ltd. CI
FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment completed the acquisition of a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd. CI
FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment agreed to acquire a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd. for KRW21.7 billion. CI
T Scientific Co.,Ltd. announced that it has received KRW 5 billion in funding from FSN Co., Ltd. CI
T Scientific Co.,Ltd. announced that it expects to receive KRW 5 billion in funding from FSN Co., Ltd. CI
FSN Co., Ltd. announced that it has received KRW 10 billion in funding from T Scientific Co.,Ltd. CI
FSN Co., Ltd. announced that it expects to receive KRW 10 billion in funding from T Scientific Co.,Ltd. and other investors CI
T Scientific Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
T Scientific Co.,Ltd signed a contract to acquire It Nomads Co., Ltd from Kim Seongjin and others for KRW 21 billion. CI
Medifron DBT Co., Ltd. announced that it has received KRW 4.0000092 billion in funding from T Scientific Co.,Ltd CI
T Scientific Co.,Ltd announced that it has received KRW 16 billion in funding from Daiduck Piping Co., Ltd. CI
T Scientific Co.,Ltd(KOSDAQ:A057680) added to S&P Global BMI Index CI
T Scientific Co.,Ltd announced that it has received KRW 4.99999914 billion in funding from WIZIT Co., Ltd. CI
T Scientific Co.,Ltd announced that it expects to receive KRW 20 billion in funding from Daiduck Piping Co., Ltd. and another investor CI
More news
1 day-0.51%
1 week-0.42%
Current month-17.84%
1 month-19.75%
3 months-22.61%
6 months-61.06%
Current year-29.83%
More quotes
1 week
1 132.00
Extreme 1132
1 279.00
1 month
1 132.00
Extreme 1132
1 449.00
Current year
1 132.00
Extreme 1132
1 975.00
1 year
1 132.00
Extreme 1132
4 230.00
3 years
1 132.00
Extreme 1132
6 620.00
5 years
950.00
Extreme 950
6 620.00
10 years
950.00
Extreme 950
13 300.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 17-03-30
Comptroller/Controller/Auditor 57 -
Members of the board TitleAgeSince
Director/Board Member 54 -
Chief Executive Officer 51 17-03-30
Director/Board Member 52 -
More insiders
Date Price Change Volume
24-04-26 1,174 -0.51% 81,862
24-04-25 1,180 -2.56% 210,000
24-04-24 1,211 +6.41% 1,040,417
24-04-23 1,138 -2.23% 168,644
24-04-22 1,164 -1.27% 235,618

End-of-day quote Korea S.E., April 25, 2024

More quotes
T Scientific Co Ltd, formerly Omnitel Inc, is a Korea-based company mainly engaged in the provision of mobile coupons. The Company mainly sells mobile gift certificates and provides mobile commerce solution services.
More about the company
  1. Stock Market
  2. Equities
  3. A057680 Stock